Category Archives: Companies

Interview with SolarWindow CEO, John Conklin

The following is a Q & A with SolarWindow Technologies (WNDW) President and CEO, John A. Conklin

1. SolarWindows are created by applying ultra-thin layers of liquid coating onto glass and flexible plastics. Are there any other substrates you are looking into? Any other uses?

No, at this time the commercialization of SolarWindow focuses on glass and flexible plastic. Plans to coat on substrates other than glass and flexible plastic is planned but not near term.

Commercial development of the SolarWindow products include:

• SolarWindow™ – Commercial, Structural, and Architectural Glass (Commercial) – Flat glass products for installation in new commercial towers under construction and replacement windows, glass walls and curtains, and textured and decorative interior glass walls, room dividers, etc

• SolarWindow™ – Residential – A window glass for installation in new residential homes under construction and replacement windows

• SolarWindow™ – BIPV – Components associated with BIPV applications in homes, buildings, and office towers

• SolarWindow™ Retrofit & Flexible Veneer – Transparent, tinted, and flexible veneers that installers can apply directly over top of existing windows on tall towers and skyscrapers

Our primary focus is first on the development and deployment of SolarWindow™-Commercial products.

Vitro Biopharma CEO Letter to Shareholders 2015

11/5/15 VODG went up 121% today after posting this press release

OTCBB: VODG

Dear Shareholders:
Concussion and traumatic brain injury (TBI) are significant health risks that lack modern therapeutic approaches beyond physical therapy and rehabilitation. The TBI incidence in the US is 1.5 to 1.7 million new cases per year and is estimated to cost $75 billion per year in the US only. Concussion is a growing issue within professional athletes including the NFL where significant health problems are derived from football-related concussion. Military service personnel and numerous others are also significantly impacted by TBI. We began development of stem cell activation technology and products during 2014 and expanded these activities in during 2015 to include treatment of concussion. We have developed patent-pending technology for treatment of neurological conditions through the activation of stem cells residing within the body. This is a process for administration of stem cell therapeutic benefit without stem cell transplants.